vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $28.9M, roughly 1.4× Outset Medical, Inc.). Cambium Networks Corp runs the higher net margin — -17.9% vs -67.5%, a 49.6% gap on every dollar of revenue. On growth, Outset Medical, Inc. posted the faster year-over-year revenue change (-2.0% vs -23.2%). Outset Medical, Inc. produced more free cash flow last quarter ($-9.7M vs $-10.8M). Over the past eight quarters, Outset Medical, Inc.'s revenue compounded faster (1.2% CAGR vs -27.2%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

CMBM vs OM — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.4× larger
CMBM
$40.3M
$28.9M
OM
Growing faster (revenue YoY)
OM
OM
+21.2% gap
OM
-2.0%
-23.2%
CMBM
Higher net margin
CMBM
CMBM
49.6% more per $
CMBM
-17.9%
-67.5%
OM
More free cash flow
OM
OM
$1.1M more FCF
OM
$-9.7M
$-10.8M
CMBM
Faster 2-yr revenue CAGR
OM
OM
Annualised
OM
1.2%
-27.2%
CMBM

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBM
CMBM
OM
OM
Revenue
$40.3M
$28.9M
Net Profit
$-7.2M
$-19.5M
Gross Margin
36.6%
42.4%
Operating Margin
-28.4%
-61.1%
Net Margin
-17.9%
-67.5%
Revenue YoY
-23.2%
-2.0%
Net Profit YoY
71.0%
24.0%
EPS (diluted)
$-0.26
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
OM
OM
Q4 25
$28.9M
Q3 25
$29.4M
Q2 25
$31.4M
Q1 25
$29.8M
Q4 24
$40.3M
$29.5M
Q3 24
$44.7M
$28.7M
Q2 24
$45.2M
$27.4M
Q1 24
$47.1M
$28.2M
Net Profit
CMBM
CMBM
OM
OM
Q4 25
$-19.5M
Q3 25
$-17.8M
Q2 25
$-18.5M
Q1 25
$-25.8M
Q4 24
$-7.2M
$-25.6M
Q3 24
$-34.5M
$-27.9M
Q2 24
$-14.2M
$-34.5M
Q1 24
$-18.4M
$-39.9M
Gross Margin
CMBM
CMBM
OM
OM
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.6%
36.5%
Q3 24
43.6%
34.3%
Q2 24
32.5%
35.7%
Q1 24
29.8%
29.2%
Operating Margin
CMBM
CMBM
OM
OM
Q4 25
-61.1%
Q3 25
-53.7%
Q2 25
-53.7%
Q1 25
-55.1%
Q4 24
-28.4%
-74.2%
Q3 24
-69.6%
-83.2%
Q2 24
-27.2%
-112.3%
Q1 24
-33.1%
-131.0%
Net Margin
CMBM
CMBM
OM
OM
Q4 25
-67.5%
Q3 25
-60.6%
Q2 25
-59.0%
Q1 25
-86.7%
Q4 24
-17.9%
-87.0%
Q3 24
-77.3%
-97.5%
Q2 24
-31.5%
-125.8%
Q1 24
-39.2%
-141.8%
EPS (diluted)
CMBM
CMBM
OM
OM
Q4 25
$0.33
Q3 25
$-1.00
Q2 25
$-1.04
Q1 25
$-3.66
Q4 24
$-0.26
$-7.21
Q3 24
$-1.22
$-8.02
Q2 24
$-0.51
$-9.96
Q1 24
$-0.66
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$67.6M
$96.2M
Stockholders' EquityBook value
$-3.2M
$127.0M
Total Assets
$173.7M
$264.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
OM
OM
Q4 25
$168.9M
Q3 25
$178.6M
Q2 25
$184.1M
Q1 25
$189.0M
Q4 24
$158.7M
Q3 24
$175.6M
Q2 24
$194.8M
Q1 24
$226.9M
Total Debt
CMBM
CMBM
OM
OM
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$67.6M
$197.4M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Stockholders' Equity
CMBM
CMBM
OM
OM
Q4 25
$127.0M
Q3 25
$142.4M
Q2 25
$154.8M
Q1 25
$169.9M
Q4 24
$-3.2M
$26.8M
Q3 24
$1.9M
$47.8M
Q2 24
$34.1M
$68.6M
Q1 24
$45.0M
$93.2M
Total Assets
CMBM
CMBM
OM
OM
Q4 25
$264.5M
Q3 25
$277.3M
Q2 25
$288.8M
Q1 25
$301.2M
Q4 24
$173.7M
$275.8M
Q3 24
$194.3M
$292.9M
Q2 24
$221.1M
$314.5M
Q1 24
$219.8M
$346.2M
Debt / Equity
CMBM
CMBM
OM
OM
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
OM
OM
Operating Cash FlowLast quarter
$-10.4M
$-9.5M
Free Cash FlowOCF − Capex
$-10.8M
$-9.7M
FCF MarginFCF / Revenue
-26.8%
-33.7%
Capex IntensityCapex / Revenue
1.1%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
OM
OM
Q4 25
$-9.5M
Q3 25
$-6.3M
Q2 25
$-4.8M
Q1 25
$-25.7M
Q4 24
$-10.4M
$-16.5M
Q3 24
$8.9M
$-20.6M
Q2 24
$2.4M
$-33.3M
Q1 24
$-15.9M
$-45.9M
Free Cash Flow
CMBM
CMBM
OM
OM
Q4 25
$-9.7M
Q3 25
$-6.5M
Q2 25
$-5.1M
Q1 25
$-25.8M
Q4 24
$-10.8M
$-16.5M
Q3 24
$6.8M
$-21.0M
Q2 24
$87.0K
$-33.5M
Q1 24
$-17.4M
$-46.3M
FCF Margin
CMBM
CMBM
OM
OM
Q4 25
-33.7%
Q3 25
-22.0%
Q2 25
-16.3%
Q1 25
-86.7%
Q4 24
-26.8%
-56.1%
Q3 24
15.2%
-73.1%
Q2 24
0.2%
-122.2%
Q1 24
-37.0%
-164.3%
Capex Intensity
CMBM
CMBM
OM
OM
Q4 25
0.8%
Q3 25
0.5%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
1.1%
0.1%
Q3 24
4.8%
1.4%
Q2 24
5.1%
0.4%
Q1 24
3.3%
1.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons